ES2054667T3 - Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso. - Google Patents

Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.

Info

Publication number
ES2054667T3
ES2054667T3 ES87303762T ES87303762T ES2054667T3 ES 2054667 T3 ES2054667 T3 ES 2054667T3 ES 87303762 T ES87303762 T ES 87303762T ES 87303762 T ES87303762 T ES 87303762T ES 2054667 T3 ES2054667 T3 ES 2054667T3
Authority
ES
Spain
Prior art keywords
arg74
des
monoclonal antibodies
production
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87303762T
Other languages
English (en)
Inventor
James W Larrick
Brian M Fendly
Tracey E Deinhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cetus Oncology Corp
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ES2054667T3 publication Critical patent/ES2054667T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRODUCEN ANTICUERPOS MONOCLONALES QUE SE CARACTERIZA POR SU APTITUD PARA COMBINARSE CON EL COMPONENTE DEL COMPLEMENTO HUMANO C5A. ESTOS ANTICUERPOS SON PARTICULARMENTE UTILES PARA EL TRATAMIENTO DE ESTADOS ASOCIADOS CON LA ACTIVACION DEL COMPLEMENTO INTRAVASCULAR NOCIVA O CAUSADOS POR ELLA. ADEMAS, ESTOS ANTICUERPOS PUEDEN UTILIZARSE EN UN METODO INMUNOLOGICO O DE INMUNODIAGNOSTICO PARA DETECTAR C5A O DES-ARG74-C5A EN HUMANOS EN FLUIDOS.
ES87303762T 1986-04-28 1987-04-28 Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso. Expired - Lifetime ES2054667T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85678086A 1986-04-28 1986-04-28
US94783986A 1986-12-30 1986-12-30

Publications (1)

Publication Number Publication Date
ES2054667T3 true ES2054667T3 (es) 1994-08-16

Family

ID=27127377

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87303762T Expired - Lifetime ES2054667T3 (es) 1986-04-28 1987-04-28 Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.

Country Status (4)

Country Link
EP (1) EP0245993B1 (es)
JP (2) JP2703764B2 (es)
DE (1) DE3785967T2 (es)
ES (1) ES2054667T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162210C (no) * 1987-07-20 1989-11-22 Fasting Biotech As Monoklonale antistoffer mot c5a for in-vitro anvendelse ved immunologiske kvantitative teknikker eller ved isolering av c5a.
DE3924924A1 (de) * 1989-07-27 1991-02-07 Goetze Otto Verfahren zum nachweis und/oder der quantitativen bestimmung von komplementpeptid c5a und/oder c5adesarg
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
US5837499A (en) * 1993-12-06 1998-11-17 Ciba-Geigy Corporation DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same
HUT75990A (en) * 1993-12-06 1997-05-28 Ciba Geigy Ag C5a receptor antagonists having substantially no agonist activity
ES2252746T3 (es) 1994-09-23 2006-05-16 Alexion Pharmaceuticals, Inc. Procedimientos para el tratamiento de la enfermedad inflamatoria articular.
US6673346B1 (en) 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
CA2457461C (en) * 2001-08-17 2013-12-24 Tanox, Inc. Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
US7455837B2 (en) * 2002-11-05 2008-11-25 The Regents Of The University Of Michigan Compositions and methods for the diagnosis and treatment of sepsis
WO2004103294A2 (en) * 2003-05-15 2004-12-02 Tanox, Inc. Methods and compositions for the prevention and treatment of sepsis
JP6022441B2 (ja) * 2010-04-30 2016-11-09 アレクシオン ファーマシューティカルズ， インコーポレイテッド 抗Ｃ５ａ抗体およびその抗体の使用のための方法
EP2468295A1 (en) 2010-12-21 2012-06-27 Affiris AG Vaccines based on peptides of the complement protein C5a
EP2666785A1 (en) 2012-05-23 2013-11-27 Affiris AG Complement component C5a-based vaccine
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
NZ711451A (en) * 2014-03-07 2016-05-27 Alexion Pharma Inc Anti-c5 antibodies having improved pharmacokinetics
KR20160147855A (ko) 2014-05-01 2016-12-23 제넨테크, 인크. 항-인자 d 항체 변이체 및 이의 용도
HK1257422A1 (zh) 2015-10-30 2019-10-18 豪夫迈‧罗氏有限公司 抗-因子d抗体变体缀合物及其用途
EP3368074A2 (en) 2015-10-30 2018-09-05 Hoffmann-La Roche AG Anti-factor d antibodies and conjugates
WO2017142055A1 (ja) * 2016-02-17 2017-08-24 国立大学法人 東京医科歯科大学 動脈硬化性疾患の発症の予測因子および検査方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.

Also Published As

Publication number Publication date
EP0245993B1 (en) 1993-05-26
DE3785967T2 (de) 1993-12-02
JPS62269699A (ja) 1987-11-24
JP2703764B2 (ja) 1998-01-26
EP0245993A3 (en) 1989-07-26
JP2820402B2 (ja) 1998-11-05
DE3785967D1 (de) 1993-07-01
EP0245993A2 (en) 1987-11-19
JPH10130167A (ja) 1998-05-19

Similar Documents

Publication Publication Date Title
BG101024A (bg) Моноклонално антитяло срещу сd44v6
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
FR1274917A (fr) Procédé de captation et de ramassage de résidus pétroliers ou autres sur les eaux portuaires, et éléments pour son application
EP0552296A4 (en) Mouse monoclonal antibodies
NL7703010A (nl) Werkwijze voor het vervaardigen van gewelfd glas en gewelfd glas, verkregen door toepassing van genoemde werkwijze.
AT265991B (de) Verfahren und Vorrichtung zur Herstellung von Gemischen, Lösungen, Emulsionen, Suspensionen u.dgl. sowie zur biologischen Reinigung von freien Gewässern
ES2062809T3 (es) Proteinas bacterianas del estres.
MX9203629A (es) Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
FR2491334B1 (es)
CL2023003331A1 (es) Anticuerpos anti-tmprs66 y usos de los mismos.
IT1044555B (it) Benzodipironi e procedimento per prepararli
DE69816796D1 (de) Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion
ES2046173T3 (es) Lineas celulares de hibridoma y sus anticuerpos monoclonales con respecto al factor estimulador de colonias de granulocitos pluripotentes humanos.
ATE96675T1 (de) Spezifische sekretions-exkretions-antigene von toxoplasma gondii, deren expressionsprodukte, verfahren zu deren herstellung und deren diagnostische und prophylaktische anwendungen.
CH417772A (de) Halbleitergerät, Verfahren zur Herstellung dieses Halbleitergerätes und Verwendung desselben
NO890046D0 (no) Disubstituerte pyridiner.
NL139179B (nl) Werkwijze voor de bereiding van preparaten met choleretische en/of hypotensieve eigenschappen, alsmede voor de bereiding van hiervoor geschikte benzothiazepine en benzothiazocine verbindingen.
ES2059418T3 (es) Antigeno asociado a carcinoma humano y anticuerpo asociado al antigeno.
DE3854267D1 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
ATE45562T1 (de) Glasgefaess, insbesondere ampulle, und verfahren zur behandlung dieses glasgefaesses.
ES8800981A1 (es) Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo
KR910016342A (ko) 항원 용액을 위한 보조제로서의 아연, 칼슘 하이드록 사이드, 렉시틴 및 pao의 용도, 및 이러한 유형의 보조제로 처리된 항원 용액
DE68919697D1 (de) Katalytische hydrofluorierung von alkenen.
AT358489B (de) Reaktor fuer kontinuierliches biologisches reinigen von abwasser, insbesondere geeignet fuer wochenendhaeuser, familienhaeuser u.dgl.
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 245993

Country of ref document: ES